2007
DOI: 10.1073/pnas.0610352104
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
57
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 57 publications
(59 citation statements)
references
References 31 publications
2
57
0
Order By: Relevance
“…Strong evidence in favor of this was recently provided by Kotenko and colleagues, who found that poxviruses encode an IFN-antagonist (46). So why do we observe such a strong dependency on IFN-␣␤ but not on IFN-in virus-activated host defense?…”
Section: Discussionmentioning
confidence: 82%
“…Strong evidence in favor of this was recently provided by Kotenko and colleagues, who found that poxviruses encode an IFN-antagonist (46). So why do we observe such a strong dependency on IFN-␣␤ but not on IFN-in virus-activated host defense?…”
Section: Discussionmentioning
confidence: 82%
“…The NS3/4A protease of HCV blocks IFN-λ production (45). A secreted glycoprotein from Yaba-like disease virus blocks IFN-λ signals (46). Vaccinia Virus inhibits IFN-λR-mediated signals and gene expression and blocks the IFN-λR antiviral response through a PKR-dependent pathway (47); moreover, a recombinant-vaccinia virus that over-expresses IFN-λ shows reduced levels of replication in vivo, indicating that poxviruses are susceptible to this interferon and have evolved mechanisms to limit its activity (22).…”
Section: Introductionmentioning
confidence: 99%
“…6). The role of the more recently discovered type III IFNs is less clear, but they are crucial for preventing influenza infection via the nasal route (7) and some viral proteins also target this subgroup (8).…”
mentioning
confidence: 99%